Clozapin-Mepha 200 mg, Tabletten

7680669370039 CH-66937 Tabletten

Associated product:

CLOZAPIN Mepha cpr 200 mg 50 pce
Clozapin-Mepha 200 mg, Tabletten
Clozapin-Mepha 200 mg, Tabletten
Clozapin-Mepha 200 mg, Tabletten
1 / 3
google

Article details

Package size
50
Selling units
50
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
25/09/2023
Patient information leaflet
Français
25/09/2023
Patient information leaflet
Italien
25/09/2023
Summary of Product Characteristics
Allemand
25/09/2023
Summary of Product Characteristics
Français
25/09/2023
Summary of Product Characteristics
Italien
25/09/2023

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
384.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 49.40
Specialties list
Yes
Generic
Yes
SL addition date: 01/01/2019

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
66937
Drug name
Clozapin-Mepha, Tabletten
Galenic form
TAB
ATC Code
N05AH02
Authorization status
Z
Dispensing category
A
First authorization
02/05/2018
Authorization expiration date
31/12/9999
IT Number
01.05.0.
Domain
Human medicine
Field of application
Neurolepticum

Package details

Description (FR)
CLOZAPIN Mepha cpr 200 mg 50 pce
Description (DE)
CLOZAPIN Mepha Tabl 200 mg 50 Stk
Market launch
02/05/2018
Narcotic (BTM)
No

Original drug

Leponex, Tabletten
GTIN: 7680374910124
CHF 17.70
View original

Other package sizes (2)

CLOZAPIN Mepha cpr 25 mg 50 pce
50 TABL
GTIN: 7680669370015
View
CLOZAPIN Mepha cpr 100 mg 50 pce
50 TABL
GTIN: 7680669370022
View